Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 5fludarabine 3pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1fiu protein, E coli 1Vincristine 1Surveys and Questionnaires 1Sugars 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Methotrexate 1Melphalan 1Loratadine 1Etoposide 1Doxorubicin 1Cholestanetriol 26-Monooxygenase 1CVAD protocol 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Burkitt Lymphoma × Sugars × Clear all
NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
1 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡